SHILPAMEDPharmaceuticals
Shilpa Medicare Ltd — Cash Flow Statement
₹348.90
+0.75%
Shilpa Medicare Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net Other Investing Changes | 1000.00 | 12.10 Cr | 1.21 Cr | 31.64 Cr | — |
| Interest Received Cfi | 8.05 Cr | 1.38 Cr | 1.28 Cr | 2.01 Cr | — |
| Net Investment Purchase And Sale | 0.94 Cr | -6.51 Cr | -8.93 Cr | -17.35 Cr | — |
| Net Business Purchase And Sale | 8.05 Cr | 11.00 Cr | -8.93 Cr | 28.41 Cr | — |
| Sale Of Business | 8.05 Cr | 11.00 Cr | 0.00 | 28.41 Cr | — |
| Net PPE Purchase And Sale | -216.13 Cr | -172.46 Cr | -226.67 Cr | -331.21 Cr | — |
| Sale Of PPE | 27.51 Cr | 12.10 Cr | 1.21 Cr | 0.61 Cr | — |
| Purchase Of PPE | -243.63 Cr | -184.56 Cr | -226.67 Cr | -331.83 Cr | — |
| Operating Cash Flow | 132.18 Cr | 136.67 Cr | 179.92 Cr | 105.13 Cr | — |
| Taxes Refund Paid | -47.02 Cr | -41.19 Cr | -32.37 Cr | -34.48 Cr | — |
| Change In Working Capital | -138.18 Cr | -67.25 Cr | 102.77 Cr | -71.99 Cr | — |
| Change In Other Current Liabilities | 54.53 Cr | -5.85 Cr | -2.20 Cr | 31.26 Cr | — |
| Change In Other Current Assets | -45.00 Cr | -9.05 Cr | 6.81 Cr | 19.69 Cr | — |
| Change In Payable | -69.94 Cr | 34.33 Cr | -2.32 Cr | 83.73 Cr | — |
| Change In Inventory | -22.32 Cr | -10.77 Cr | 35.42 Cr | -38.40 Cr | — |
| Change In Receivables | -55.45 Cr | -75.90 Cr | 65.06 Cr | -168.27 Cr | — |
| Other Non Cash Items | 57.63 Cr | 86.79 Cr | 56.07 Cr | 37.69 Cr | — |
| Provisionand Write Offof Assets | 6.34 Cr | 2.61 Cr | 6.03 Cr | 0.00 | — |
| Depreciation And Amortization | 112.99 Cr | 107.87 Cr | 95.50 Cr | 79.80 Cr | — |
| Depreciation | 112.99 Cr | 107.87 Cr | 95.50 Cr | 79.80 Cr | — |
| Gain Loss On Investment Securities | -4.26 Cr | -7.20 Cr | 0.26 Cr | 1.60 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -4.31 Cr | 0.85 Cr | -4.06 Cr | -3.80 Cr | — |
| Net Income From Continuing Operations | 122.33 Cr | 54.34 Cr | -38.28 Cr | 102.26 Cr | — |
| Free Cash Flow | -111.46 Cr | -47.89 Cr | -46.74 Cr | -226.69 Cr | — |
| Issuance Of Capital Stock | 489.10 Cr | 0.00 | 0.00 | 296.84 Cr | — |
| Capital Expenditure | -243.63 Cr | -184.56 Cr | -226.67 Cr | -331.83 Cr | — |
| End Cash Position | 28.52 Cr | 31.76 Cr | 19.07 Cr | 25.34 Cr | — |
| Other Cash Adjustment Outside Changein Cash | 2000.00 | -10000.00 | — | 1000.00 | 1000.00 |
| Beginning Cash Position | 31.76 Cr | 19.07 Cr | 25.62 Cr | 122.85 Cr | — |
| Effect Of Exchange Rate Changes | 1.02 Cr | -4.17 Cr | 0.34 Cr | — | -0.14 Cr |
| Changes In Cash | -4.25 Cr | 16.86 Cr | -6.89 Cr | -97.51 Cr | — |
| Financing Cash Flow | 62.65 Cr | 46.77 Cr | 45.80 Cr | 82.86 Cr | — |
| Net Other Financing Charges | 2000.00 | -1000.00 | 1000.00 | -1000.00 | — |
| Interest Paid Cff | -76.73 Cr | -92.37 Cr | -57.92 Cr | -41.38 Cr | — |
| Net Common Stock Issuance | 489.10 Cr | 0.00 | 0.00 | 296.84 Cr | — |
| Common Stock Issuance | 489.10 Cr | 0.00 | 0.00 | 296.84 Cr | — |
| Net Issuance Payments Of Debt | -349.17 Cr | 139.67 Cr | 113.81 Cr | -163.05 Cr | — |
| Net Short Term Debt Issuance | -53.87 Cr | 16.37 Cr | 141.26 Cr | -41.56 Cr | — |
| Net Long Term Debt Issuance | -295.30 Cr | 123.30 Cr | -27.45 Cr | -121.49 Cr | — |
| Investing Cash Flow | -199.08 Cr | -166.58 Cr | -232.61 Cr | -285.50 Cr | — |
| Dividends Received Cfi | — | 0.00 | 0.50 Cr | 1.00 Cr | 0.48 Cr |
| Purchase Of Business | — | -6.51 Cr | -8.93 Cr | 0.00 | -62.44 Cr |
| Cash Dividends Paid | — | — | -9.55 Cr | -8.97 Cr | — |
| Amortization Cash Flow | — | — | 13.63 Cr | — | — |
| Gain Loss On Sale Of Business | — | — | 0.00 | -8.79 Cr | -60.84 Cr |
| Common Stock Dividend Paid | — | — | — | -8.97 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Shilpa Medicare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.